You are using an older version of Internet Explorer that is not supported on this site. Please upgrade for the best experience.

Gynecologic Cancer Trials

Click on a trial to find out the eligibility requirements and who to contact if you have questions about participating.

Page 1 of 2 | Results 1 - 10 of 13

A PHASE II EVALUATION OF COPANLISIB (BAY 80-6946) (IND #130822), A SELECTIVE INHIBITOR OF PI3KCA, IN PATIENTS WITH PERSISTENT OR RECURRENT ENDOMETRIAL CARCINOMA HARBORING PIK3CA HOTSPOT MUTATIONS

James Hoffman, MD
Cancer, Cancer-Gynecologic

D'Amour Center for Cancer Care

3350 Main Street
Springfield, MA 01199

A PHASE III, MULTICENTER, RANDOMIZED, STUDY OF ATEZOLIZUMAB VERSUS PLACEBO ADMINISTERED IN COMBINATION WITH PACLITAXEL, CARBOPLATIN, AND BEVACIZUMAB TO PATIENTS WITH NEWLY-DIAGNOSED STAGE III OR STAGE IV OVARIAN, FALLOPIAN TUBE, OR PRIMARY PERITONEAL CANCER (GOG 3015)

James Hoffman, MD
Cancer-Gynecologic, Cancer

D'Amour Center for Cancer Care

3350 Main Street
Springfield, MA 01199

A Phase II Trial Evaluating Cisplatin (NSC #119875) And Gemcitabine (NSC # 613327) Concurrent With Intensity-Modulated Radiation Therapy (IMRT) In The Treatment Of Locally Advanced Squamous Cell Carcinoma Of The Vulva

The purpose of this study is to find out if radiation therapy along with the addition of the drugs, cisplatin and gemcitabine, works and to find out what side effects or surgical complications are caused by treatment with this combination.
Tashanna Myers, MD
Cancer-Gynecologic, Cancer

D’Amour Center for Cancer Care

3350 Main Street, Springfield MA 01199

Franklin Medical Center

164 High Street, Greenfield MA

A Randomized Phase III Study Of Standard Vs. IMRT Pelvic Radiation For Post-Operative Treatment Of Endometrial And Cervical Cancer (Time-C)

The purpose of this study is to test whether the use of a radiation therapy delivery technique called intensity-modulated radiation therapy (IMRT) can reduce the amount and severity of gastrointestinal side effects (such as diarrhea) that result from radiation, compared with standard radiation techniques
Seth Kaufman, MD
Cancer-Gynecologic, Cancer

D’Amour Center for Cancer Care

3350 Main Street, Springfield MA 01199

AstraZeneca Pharmaceuticals LP D0816L00003 Non-Randomized, Open-Label Phase II Study to Assess Olaparib Tablets as a Treatment for Subjects with Different HRD Tumor Status and with Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That Have Received at Least 2 Prior Lines of Chemotherapy

James Hoffman, MD
Cancer, Cancer-Gynecologic

D'Amour Center for Cancer Care

3350 Main Street
Springfield, MA 01199

G270: Groningen International Study on Sentinel Nodes in Vulvar Cancer (GROINSS-V) II: An Observational Study

Observational study: To investigate the safety of replacing complete inguino femoral lymphadenectomy by adjuvant radiotherapy in early stage vulvar cancer patients with a sentinel node metastasis < or = 2 mm
Tashanna Myers, MD
Cancer, Cancer-Gynecologic

D’Amour Center for Cancer Care

3350 Main Street

Springfield MA 01199 

And

Franklin Medical Center,

164 High Street

Greenfield MA

G274: A Phase III Trial for Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The Outback Trial

The purpose of this study is to compare standard treatment, radiation therapy combined with the chemotherapy drug cisplatin, to standard chemo-radiation therapy plus additional experimental chemotherapy to see if it reduces the risk of tumor recurrence and improves overall survival.
Tashanna Myers, MD
Cancer-Gynecologic, Cancer, OB Gyn

D’Amour Center for Cancer Care

3350 Main Street

Springfield MA 01199

And

Franklin Medical Center

164 High Street

Greenfield MA

NCI/CIRB EAY131 Molecular Analysis for Therapy Choice (MATCH)

John McCann, MD
Cancer, Cancer - Brain, Cancer - Breast, Cancer - Colon, Cancer - Esophogus, Cancer-Gynecologic, Cancer - Kidney, Cancer - Leukemia, Cancer - Lung, Cancer - Lymphoma, Cancer - Melanoma, Cancer - Multiple Myeloma, Cancer - Pancreatic, Cancer - Prostate

D'Amour Center For Cancer Care

3350 Main Street
Springfield, MA 01199

NCI/CIRB GOG 263 RANDOMIZED PHASE III CLINICAL TRIAL OF ADJUVANT RADIATION VERSUS CHEMORADIATION IN INTERMEDIATE RISK, STAGE I/IIA CERVICAL CANCER TREATED WITH INITIAL RADICAL HYSTERECTOMY AND PELVIC LYMPHADENECTOMY

Tashanna Myers, MD
Cancer, Cancer-Gynecologic

D'Amour Center for Cancer Care

3350 Main Street
Springfield, MA 01199

NCI/CIRB S1609 DART: DUAL ANTI-CTLA-4 AND ANTI-PD-1 BLOCKADE IN RARE TUMORS

John McCann, MD
Cancer, Cancer - Brain, Cancer - Breast, Cancer - Colon, Cancer - Esophogus, Cancer-Gynecologic, Cancer - Kidney, Cancer - Leukemia, Cancer - Lung, Cancer - Lymphoma, Cancer - Melanoma, Cancer - Multiple Myeloma, Cancer - Pancreatic, Cancer - Prostate

D'Amour Center for Cancer Care

3350 Main Street
Springfield, MA 01199

Page 1 of 2 | Results 1 - 10 of 13